A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies | MicrobiomeTrials
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2024-08-16Est. Completion: 2026-07-14
Enrollment target: 12 participants
Locations
City of Hope, Duarte, California, United States
Moffitt Cancer Center, Tampa, Florida, United States
Emory University - Winship Cancer Institute, Atlanta, Georgia, United States
Henry Ford Cancer Institute, Detroit, Michigan, United States
Oregon Health and Science University, Portland, Oregon, United States
TriStar Bone Marrow Transplant, Nashville, Tennessee, United States
St. David's South Austin Medical Center, Austin, Texas, United States
Methodist Hospital, Texas Transplant, San Antonio, Texas, United States
University of Utah - Huntsman Cancer Institute, Salt Lake City, Utah, United States
Other microbiome trials you might be interested in